Dosing patterns, healthcare resource utilization and costs among acromegaly patients who consistently use lanreotide and injectable octreotide

Aim: In the US, lanreotide and injectable octreotide are commonly used to treat acromegaly. For most patients, the recommended injection administration regimen is every 4 weeks, or 13-times over the course of 1 year. The study aimed to quantify the proportion of patients who used a number of injec...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Tiffany P Quock, Eunice Chang, Ashis K Das, Amanda Speller, Marian H Tarbox, Stacy K Rattana, Ingrid E Paulson, Michael S Broder
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Becaris Publishing Limited 2025-07-01
Reeks:	Journal of Comparative Effectiveness Research
Onderwerpen:	acromegaly dosing high-dose high-frequency treatment wastage
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!